Journal articles on the topic 'Cancer, n.e.c'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Cancer, n.e.c.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Cohn, Allen Lee, Michael Seiden, Kathryn N. Kurtzman, Earl Hubbell, Samuel Gross, Oliver Venn, Eric T. Fung, et al. "The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 5574. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.5574.
Full textFurihata, Chie, Akira Yamakoshi, Akiko Hatta, Masae Tatematsu, Hitoshi Iwata, Kenshi Hayashi, Kazuo Umezawa, and Taijiro Matsushima. "Induction of c-fos and c-myc oncogene expression in the pyloric mucosa of rat stomach by N-methyl-N′-nitro-N-nitrosoguanidine and taurocholate." Cancer Letters 83, no. 1-2 (August 1994): 215–20. http://dx.doi.org/10.1016/0304-3835(94)90322-0.
Full textDIAS, P., P. KUMAR, H. B. MARSDEN, H. R. GATTAMANENI, and S. KUMAR. "N-and c-myc Oncogenes in Childhood Rhabdomyosarcoma." JNCI Journal of the National Cancer Institute 82, no. 2 (January 17, 1990): 151. http://dx.doi.org/10.1093/jnci/82.2.151.
Full textBorrello, Maria G., Giusi Carbone, Marco A. Pierotti, Alessandra Molla, and Giuseppe Della Porta. "Activated c-K-ras and c-N-ras oncogenes in 3-methylcholanthrene-induced BALB/c fibrosarcomas." Carcinogenesis 9, no. 8 (1988): 1517–19. http://dx.doi.org/10.1093/carcin/9.8.1517.
Full textPutzrath, Resha. "Studying Cancer Human Carcinogenesis Curtis C. Harris Herman N. Autrup." BioScience 35, no. 1 (January 1985): 51. http://dx.doi.org/10.2307/1310088.
Full textLin, D. X., M. Friesen, C. Malaveille, D. E. G. Shuker, and H. Bartsch. "Urinary excretion of S-benzylmercapturic acid as an indicator of N-nitroso-N-methylbenzylamine exposure." Cancer Letters 57, no. 3 (May 1991): 193–98. http://dx.doi.org/10.1016/0304-3835(91)90156-c.
Full textdi Luccio, Eric, Masayo Morishita, and Takaaki Hirotsu. "C. elegans as a Powerful Tool for Cancer Screening." Biomedicines 10, no. 10 (September 23, 2022): 2371. http://dx.doi.org/10.3390/biomedicines10102371.
Full textWilliams, Morwen, Adam I. Green, Julio Fernandez-Cestau, David L. Hughes, Maria A. O'Connell, Mark Searcey, Benoît Bertrand, and Manfred Bochmann. "(C^Npz^C)AuIII complexes of acyclic carbene ligands: synthesis and anticancer properties." Dalton Trans. 46, no. 39 (2017): 13397–408. http://dx.doi.org/10.1039/c7dt02804k.
Full textTishchenko, V. K., V. M. Petriev, E. D. Stepchenkova, P. V. Shegai, S. A. Ivanov, and A. D. Kaprin. "The influence of temperature on biodistribution of N,N,N’,N’- ethylenediaminetetrakis(methylene phosphonic) acid labeled with gallium-68." Journal of Physics: Conference Series 2058, no. 1 (October 1, 2021): 012042. http://dx.doi.org/10.1088/1742-6596/2058/1/012042.
Full textChu, Pei-Yi, Hsing-Ju Wu, Shin-Mae Wang, Po-Ming Chen, Feng-Yao Tang, and En-Pei Isabel Chiang. "MAT2A Localization and Its Independently Prognostic Relevance in Breast Cancer Patients." International Journal of Molecular Sciences 22, no. 10 (May 20, 2021): 5382. http://dx.doi.org/10.3390/ijms22105382.
Full textBhattarai, Nimisha, Jieqiong Wang, Daniel Nguyen, Xiaoxiao Yang, Linh Helmers, Jennifer Paruch, Li Li, et al. "Abstract 6372: Nanodrug delivery system for non-genotoxic p53 activator INZ-C." Cancer Research 82, no. 12_Supplement (June 15, 2022): 6372. http://dx.doi.org/10.1158/1538-7445.am2022-6372.
Full textReno, Elaine M., James M. Haughian, Twila A. Jackson, Alicia M. Thorne, and Andrew P. Bradford. "c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells." Apoptosis 14, no. 6 (May 8, 2009): 809–20. http://dx.doi.org/10.1007/s10495-009-0354-6.
Full textShulin, Wang, Zhang Yaozheng, and Yokihiro Matsugama. "C-erbB-2, p53, N-ras expression in hepatocellular carcinoma." Chinese Journal of Cancer Research 8, no. 3 (September 1996): 178–82. http://dx.doi.org/10.1007/bf02675484.
Full textHurd, Cliff, Richard T. Waldron, and Enrique Rozengurt. "Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus." Oncogene 21, no. 14 (March 2002): 2154–60. http://dx.doi.org/10.1038/sj.onc.1205290.
Full textD'Angelo, Sandra, Meredith Deutscher, Maura Dickler, and David M. Weinstock. "Hepatitis C Virus Infection Does Not Preclude Standard Breast Cancer–Directed Therapy." Clinical Breast Cancer 9, no. 1 (February 2009): 51–52. http://dx.doi.org/10.3816/cbc.2009.n.009.
Full textRamón, Jorge, Laura Rodriguez Rey, Luis Eduardo García, Darío Sánchez Cabrero, Oliver Higuera, Alejandro Gallego, Leticia Ruiz Gimenez, and Nuria Rodriguez Salas. "Prevalence & pathogenic features of hereditary breast/ovarian cancer syndromes: Implementation of a genetic/familiar cancer risk assessment unit." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13645-e13645. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13645.
Full textPortal, M. M., G. O. Ferrero, and B. L. Caputto. "N-Terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation." Oncogene 26, no. 24 (December 11, 2006): 3551–58. http://dx.doi.org/10.1038/sj.onc.1210137.
Full textWatson, Patrice, Rita Lieberman, Carrie Snyder, Vanessa J. Clark, Henry T. Lynch, and Jeffrey T. Holt. "Detecting BRCA2 Protein Truncation in Tissue Biopsies to Identify Breast Cancers That Arise in BRCA2 Gene Mutation Carriers." Journal of Clinical Oncology 27, no. 24 (August 20, 2009): 3894–900. http://dx.doi.org/10.1200/jco.2008.20.5211.
Full textSnyder, Jeremy, Marco Zenone, and Timothy Caulfield. "Crowdfunding for complementary and alternative medicine: What are cancer patients seeking?" PLOS ONE 15, no. 11 (November 20, 2020): e0242048. http://dx.doi.org/10.1371/journal.pone.0242048.
Full textTatematsu, Masae, Kumiko Ogawa, Toru Hoshiya, Yutaka Shichino, Toshio Kato, Katsumi Imaida, and Nobuyuki Ito. "Induction of Adenocarcinomas in the Glandular Stomach of BALB/c Mice Treated with N-Methyl-N-nitrosourea." Japanese Journal of Cancer Research 83, no. 9 (September 1992): 915–18. http://dx.doi.org/10.1111/j.1349-7006.1992.tb01999.x.
Full textKim, Jung-Mi, Jung-Dae Kim, Rina Yu, Byung-Sam Kim, Mi-Kyung Shin, and In-Seob Han. "Effects of capsaicin on induction of c-jun proto-oncogene expression in Fisher-344 rats by N-methyl-N′-nitro-N-nitrosoguanidine." Cancer Letters 142, no. 2 (August 1999): 155–60. http://dx.doi.org/10.1016/s0304-3835(99)00154-8.
Full textLuzzatto, Lucio, Flavia Colonna, and Irene Reilly. "The “n-1” model for myelodysplastic syndromes." Leukemia Research 16, no. 1 (January 1992): 57–59. http://dx.doi.org/10.1016/0145-2126(92)90101-c.
Full textMusto, Pellegrino. "Hepatitis C Virus Infection and B-Cell Non-Hodgkin's Lymphomas: More Than a Simple Association." Clinical Lymphoma 3, no. 3 (December 2002): 150–60. http://dx.doi.org/10.3816/clm.2002.n.021.
Full textLahn, Michael, Chen Su, Shuyu Li, Marcio Chedid, Kimberly R. Hanna, Jeremy R. Graff, George E. Sandusky, et al. "Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer." Clinical Lung Cancer 6, no. 3 (November 2004): 184–89. http://dx.doi.org/10.3816/clc.2004.n.032.
Full textMa, Liandong, Yuzhi Tong, Zhaohui Yang, Qianxiang Zhou, Honghua Yan, Ye Chen, Dong Chen, Ru Xu, Yini Wang, and Jun Qin. "Abstract A03: Discovery and evaluation of GT19630, a c-Myc/n-Myc degrader, for targeting c-Myc-driven B-cell malignancies, acute myeloid leukemia (AML) and n-Myc driven cancers." Blood Cancer Discovery 3, no. 5_Supplement (September 6, 2022): A03. http://dx.doi.org/10.1158/2643-3249.lymphoma22-a03.
Full textPracht, Marc, Ariane Mogha, Alain Fautrel, Alexandra Lespagnol, Nicolas Mouchet, Francois Le Gall, Emmanuel Oger, Marie-Dominique Galibert, and Thierry Lesimple. "C-kit, B-raf, and N-ras mutations in melanoma subtypes." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e19037-e19037. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e19037.
Full textWang, Y., and S. R. McAlpine. "N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes." Chemical Communications 51, no. 8 (2015): 1410–13. http://dx.doi.org/10.1039/c4cc07284g.
Full textChambers, Laura, Xuefei Jia, and Mariam Alhilli. "Impact of neoadjuvant chemotherapy on survival in women with endometrial cancer: A National Cancer Database analysis." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e18094-e18094. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e18094.
Full textWyrwicz, Lucjan, Elena Elimova, Steven I. Blum, Hong Xiao, Eric Davenport, Jinyi Wang, Shannon Hunter, Mingshun Li, Kaoru Kondo, and Markus H. Moehler. "Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): Interim results of nivolumab plus chemotherapy (N+C) versus (C) from CheckMate 649." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 4066. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.4066.
Full textKumar, R., P. Mende, A. R. Tricker, M. Siddiqi, and R. Preussmann. "N-Nitroso compounds and their precursors in Brassica oleracea." Cancer Letters 54, no. 1-2 (October 1990): 61–65. http://dx.doi.org/10.1016/0304-3835(90)90092-c.
Full textTakahashi, Ryota, Yoshihiro Hirata, Kosuke Sakitani, Wachiko Nakata, Hiroto Kinoshita, Yoku Hayakawa, Hayato Nakagawa, et al. "Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer." Cancer Science 104, no. 3 (January 24, 2013): 337–44. http://dx.doi.org/10.1111/cas.12080.
Full textZhou, Xue-Quan, Anja Busemann, Michael S. Meijer, Maxime A. Siegler, and Sylvestre Bonnet. "The two isomers of a cyclometallated palladium sensitizer show different photodynamic properties in cancer cells." Chemical Communications 55, no. 32 (2019): 4695–98. http://dx.doi.org/10.1039/c8cc10134e.
Full textMaruzzo, Marco, Alberto Bortolami, Dario Palleschi, Andrea Zivi, Maurizio Nicodemo, Donata Sartori, Rocco De Vivo, et al. "Use of nivolumab (N) and cabozantinib (C) for treatment of the metastatic renal cell carcinoma (mRCC) in the Veneto region: Results of AMOUR study." Journal of Clinical Oncology 39, no. 6_suppl (February 20, 2021): 290. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.290.
Full textAlkrekshi, Akram, Raul Arroyo Suarez, and Ahmad Nader Kassem. "Excess body weight association with various cancer: A United States population-based study 2021." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e18558-e18558. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e18558.
Full textSaura, Cristina, Mafalda Oliveira, Yin-Hsun Feng, Ming-Shen Dai, Sara A. Hurvitz, Sung-Bae Kim, Beverly Moy, et al. "Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 1002. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1002.
Full textCrudele, Julie M., Geerte L. Van Sluis, Paris Margaritis, Joshua I. Siner, Michael Sliozberg, Jenna Maurer, Armida Faella, et al. "Insights Into the Mechanism of Zymogen Protein C Protection Against Cancer Progression." Blood 120, no. 21 (November 16, 2012): 3350. http://dx.doi.org/10.1182/blood.v120.21.3350.3350.
Full textWiench, Karin, Eva Frei, Peter Schroth, and Manfred Wiessler. "1-C-Glucuronidation of N-nitrosodiethylamine and N-nitrosomethyl-n-pentylamine in vivo and in primary hepatocytes from rats pretreated with inducers." Carcinogenesis 13, no. 5 (1992): 867–72. http://dx.doi.org/10.1093/carcin/13.5.867.
Full textLee, Sang-Haak, Tingan Chen, Jun Zhou, Jennifer Hofmann, and Gerold Bepler. "Protein Kinase C-β Gene Variants, Pathway Activation, and Enzastaurin Activity in Lung Cancer." Clinical Lung Cancer 11, no. 3 (May 2010): 169–75. http://dx.doi.org/10.3816/clc.2010.n.021.
Full textShi, Liu, Yu Xiong, and Xiaoyan Hu. "MicroRNA-1254 Suppresses Epithelial-Mesenchymal Transition by Upregulating c-Cellular Myelocytomatosis Oncogene (c-Myc) and Alleviates Drug Resistance in Lung Cancer." Journal of Biomaterials and Tissue Engineering 11, no. 11 (November 1, 2021): 2146–52. http://dx.doi.org/10.1166/jbt.2021.2794.
Full textOelgeschläger, Michael, Elisabeth Kowenz-Leutz, Sabine Schreek, Achim Leutz, and Bernhard Lüscher. "Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP." Oncogene 20, no. 50 (November 2001): 7420–24. http://dx.doi.org/10.1038/sj.onc.1204922.
Full textKramer, Mario W., Annika Heinisch, Gerd Wegener, Mahmoud Abbas, Inga Peters, Christoph A. J. von Klot, Hossein Tezval, Thomas R. W. Herrmann, Markus A. Kuczyk, and Axel S. Merseburger. "C-reactive protein prior to cystectomy: An external validation of the TNR-C score." Journal of Clinical Oncology 32, no. 4_suppl (February 1, 2014): 344. http://dx.doi.org/10.1200/jco.2014.32.4_suppl.344.
Full textJanku, Filip, Siqing Fu, Ravi Murthy, Daniel Karp, David Hong, Apostolia Tsimberidou, Maura Gillison, et al. "383 First-in-man clinical trial of intratumoral injection of clostridium Novyi-NT spores in combination with pembrolizumab in patients with treatment-refractory advanced solid tumors." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A408. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0383.
Full textSofi, Firdoos Ahmad, and Prasad V. Bharatam. "Synthesis of Drugs and Biorelevant N-heterocycles Employing Recent Advances in C-N Bond Formation." Current Organic Chemistry 24, no. 20 (December 2, 2020): 2293–340. http://dx.doi.org/10.2174/1385272824999200909114144.
Full textSofi, Firdoos Ahmad, and Prasad V. Bharatam. "Synthesis of Drugs and Biorelevant N-heterocycles Employing Recent Advances in C-N Bond Formation." Current Organic Chemistry 24, no. 20 (October 2020): 2293–340. http://dx.doi.org/10.2174/138527282499920090911414.
Full textLatham, Sharissa L., Yolande E. I. O'Donnell, and David R. Croucher. "Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatments." Biochemical Society Transactions 50, no. 6 (December 1, 2022): 1823–36. http://dx.doi.org/10.1042/bst20220808.
Full textYao, Ke, Hanyong Chen, Mee-Hyun Lee, Haitao Li, Weiya Ma, Cong Peng, Nu Ry Song, et al. "Licochalcone A, a Natural Inhibitor of c-Jun N-Terminal Kinase 1." Cancer Prevention Research 7, no. 1 (November 19, 2013): 139–49. http://dx.doi.org/10.1158/1940-6207.capr-13-0117.
Full textSlingerland, R. J., A. H. Van Gennip, J. M. Bodlaender, P. A. Voǔte, and A. B. P. Van Kuilenburg. "Cyclopentenyl cytosine and neuroblastoma SK-N-BE(2)-C cell line cells." European Journal of Cancer 31, no. 4 (January 1995): 627–31. http://dx.doi.org/10.1016/0959-8049(95)00071-p.
Full textSaura, Cristina, Mafalda Oliveira, Yin-Hsun Feng, Ming-Shen Dai, Shang-Wen Chen, Sara A. Hurvitz, Sung-Bae Kim, et al. "Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial." Journal of Clinical Oncology 38, no. 27 (September 20, 2020): 3138–49. http://dx.doi.org/10.1200/jco.20.00147.
Full textNierenberg, Jovia L., Linda Kachuri, Taylor B. Cavazos, Rebecca E. Graff, Thomas J. Hoffmann, Jie Zhang, Stacey Alexeeff, et al. "Abstract 1446: Genetic risk factors for the development of multiple primary cancers." Cancer Research 82, no. 12_Supplement (June 15, 2022): 1446. http://dx.doi.org/10.1158/1538-7445.am2022-1446.
Full textSatoi, S., H. Yanagimoto, S. Takai, H. Toyokawa, K. Takahashi, N. Terakawa, T. Yamamoto, and Y. Kamiyama. "Circulating dendritic cell as a new prognostic factor in pancreatic cancer patients." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 4095. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4095.
Full text